Skip to content
Live
Market Cap:$2.80T+0.9%
24h Vol:$117.3B
BTC:58.3%
ETH:11.5%
Coins:21,308

Bio Protocol (BIO) — DCA Calculator

Calculate the returns of Dollar-Cost Averaging into Bitcoin and other cryptocurrencies.

157 data points · 2026-04-152026-09-18 · BIO real prices

DCA Simulation Results

Total Invested

$2,300.00

Estimated Value

$2,234.46

Return on Investment

-2.8%

Profit / Loss

-$65.536246

Avg. Cost Basis

$0.029253

Total Purchases

23

This simulation uses approximated historical return patterns. Actual results vary. Past performance does not guarantee future returns. This is not financial advice.

What is Dollar Cost Averaging for Bio Protocol?

Dollar Cost Averaging (DCA) is an investment strategy where you regularly invest a fixed amount into Bio Protocol (BIO) — regardless of the current price. This strategy reduces the risk of buying at the wrong time and smooths out your average purchase price over time.

Secure Your Crypto

If you're regularly investing in Bio Protocol, you need secure storage. Hardware wallets protect your investment offline.

Bio Protocol in Market Context

Market Position

Bio Protocol (BIO) ranks #419 outside the top 100 — higher upside potential paired with significantly elevated liquidity and delisting risk, with a current market cap of $61.02 M. Bio Protocol falls into a specialized category with valuation drivers that differ from mainstream L1s and DeFi tokens.

Recent Price Action

At $0.0284 (only 3% of the ATH of $0.8890), Bio Protocol is in a deep correction — drawdowns of this magnitude have historically offered attractive re-entry zones depending on fundamentals. Over the last 7 days, Bio Protocol has gained +7.3%; over 30 days it has dropped −16.4%.

Valuation Signals

A Value Score of 65.6/100 places Bio Protocol in the "Undervalued" zone, indicating a discount versus realized market cap and network activity. MVRV at 95/100 suggests a favorable valuation relative to realized cap. Low dev activity (score 0/100) is a cluster risk — project stagnation elevates long-term delisting risk. The NVT ratio (90/100) shows healthy network activity relative to market cap.

Risk Profile

Specialized tokens carry use-case concentration risk: if the core thesis fails, pivoting is rarely viable. Outside the top 100, exchange liquidity is thin and slippage on larger trades is non-trivial.

Never Miss an Opportunity

Get weekly DCA analysis, score changes, and undervalued coins delivered straight to your inbox.

Subscribe to Newsletter

Bio Protocol Fundamental Analysis

Value Score, metrics, chart and more for BIO

View Analysis →